8217.HK
Get informed when a big investor buys or sells
+ FollowOvervalued by 132.2% based on the discounted cash flow analysis.
| Market cap | $31.09 Million |
|---|---|
| Enterprise Value | $34.09 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.08 |
| Beta | 0.63 |
| Outstanding Shares | 303,065,000 |
| P/E Ratio | 0.89 |
|---|---|
| PEG | -0.35 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.61 |
| Enterprise Value to EBIT | 2.37 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.36 |
| Debt to Equity | 0.24 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
"As an investment holding company, Ju Fu Tang Biotech Holdings Co., Ltd primarily delivers a comprehensive range of civil engineering, decoration, and renovation services across Hong Kong. Its extensive portfolio covers infrastructure de...